20.83
+0.55(+2.71%)
Currency In USD
Address
300 Kimball Drive
Parsippany, NJ 07054
United States of America
Phone
201 847 6880
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2200
First IPO Date
March 22, 2022
| Name | Title | Pay | Year Born |
| Mr. Devdatt Kurdikar | President, Chief Executive Officer & Director | 2.2M | 1969 |
| Mr. Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain | 915,666 | 1969 |
| Mr. Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary | 959,453 | 1972 |
| Mr. Jacob P. Elguicze | Senior Vice President & Chief Financial Officer | 1.05M | 1973 |
| Ms. Jean M. Casner | Senior Vice President & Chief Human Resources Officer | 0 | 1958 |
| Mr. Tom Blount | Senior Vice President & President of North America | 0 | 1974 |
| Ms. Colleen Riley | Senior Vice President & Chief Technology Officer | 0 | 1964 |
| Mr. Pravesh Khandelwal | Vice President & Head of Investor Relations | 0 | N/A |
| Ms. Ginny Blocki | Senior Vice President of Global Marketing & Product Management | 0 | N/A |
| Mr. Slobodan Radumilo | Senior Vice President & President of International | 0 | 1970 |
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.